药明巨诺-话题@MedSci

#药明巨诺#

4篇内容 | 681人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1465295, encodeId=28e11465295e9, content=<a href='/topic/show?id=b2558e603fb' target=_blank style='color:#2F92EE;'>#药明巨诺#</a>, objectTitle=药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批, objectType=article, longId=724745, objectId=639fe24745ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=639fe24745ff, replyNumber=0, likeNumber=17, createdTime=2022-04-23, rootId=0, userName=zhucaizhong7768, userId=d57a6693515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=639fe24745ff, moduleTitle=药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=639fe24745ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1465294, encodeId=a20014652949e, content=<a href='/topic/show?id=b2558e603fb' target=_blank style='color:#2F92EE;'>#药明巨诺#</a>, objectTitle=药明巨诺上市, objectType=article, longId=202869, objectId=e58e202869c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e58e202869c5, replyNumber=0, likeNumber=31, createdTime=2020-11-05, rootId=0, userName=zhucaizhong7768, userId=d57a6693515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e58e202869c5, moduleTitle=药明巨诺上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e58e202869c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1465293, encodeId=12d814652935c, content=<a href='/topic/show?id=b2558e603fb' target=_blank style='color:#2F92EE;'>#药明巨诺#</a>, objectTitle=CDE公示第4个拟突破性治疗品种：药明巨诺CAR-T疗法, objectType=article, longId=200518, objectId=c7512005180b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7512005180b, replyNumber=0, likeNumber=32, createdTime=2020-09-12, rootId=0, userName=zhucaizhong7768, userId=d57a6693515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7512005180b, moduleTitle=CDE公示第4个拟突破性治疗品种：药明巨诺CAR-T疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7512005180b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1465292, encodeId=902f1465292c2, content=<a href='/topic/show?id=b2558e603fb' target=_blank style='color:#2F92EE;'>#药明巨诺#</a>, objectTitle=药明巨诺研发中心在沪落成助推细胞免疫治疗纵深创新, objectType=article, longId=155710, objectId=ea78155e10f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea78155e10f0, replyNumber=0, likeNumber=34, createdTime=2018-12-14, rootId=0, userName=zhucaizhong7768, userId=d57a6693515, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea78155e10f0, moduleTitle=药明巨诺研发中心在沪落成助推细胞免疫治疗纵深创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea78155e10f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药明巨诺

2020-05-29

zhucaizhong7768 (审核中...)

前往app查看评论内容

#药明巨诺#

药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批

2022-04-23

zhucaizhong7768 (审核中...)

前往app查看评论内容

#药明巨诺#

药明巨诺上市

2020-11-05

zhucaizhong7768 (审核中...)

前往app查看评论内容

#药明巨诺#

CDE公示第4个拟突破性治疗品种：药明巨诺CAR-T疗法

2020-09-12

zhucaizhong7768 (审核中...)

前往app查看评论内容

#药明巨诺#

药明巨诺研发中心在沪落成助推细胞免疫治疗纵深创新

2018-12-14

科室
- - 订阅+
  - 更多科室
工具
服务